J&J says Rybrevant combo bests AstraZenecas Tagrisso in type of lung cancer
…
71,750€
1,06%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%
The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
AstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company should be able to repeat this feat over…
This Pharma Stock Is Poised to Keep Outperforming the S&P 500 @themotleyfool #stocks $AZN
AstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company should be able to repeat this feat over…
ANALYSE-FLASH: Goldman startet Astrazeneca mit Buy - Ziel 15200 Pence
NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat die Bewertung der Aktien von Astrazeneca bei einem Kursziel…